Solventum Corp. (SOLV)
90.96
-0.10
(-0.11%)
USD |
NYSE |
Sep 01, 16:00
90.96
0.00 (0.00%)
After-Hours: 20:00
Solventum Research and Development Expense (Annual) : 727.00M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 727.00M |
| December 31, 2024 | 768.00M |
| December 31, 2023 | 758.00M |
| Date | Value |
|---|---|
| December 31, 2022 | 767.00M |
| December 31, 2021 | 766.00M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Stryker Corp. | 1.567B |
| Zimmer Biomet Holdings, Inc. | 458.50M |
| Edwards Lifesciences Corp. | 1.079B |
| Intuitive Surgical, Inc. | 1.312B |
| Inspire Medical Systems, Inc. | 103.16M |